Treatment of Alzheimer's disease: from pharmacology to a better understanding of disease pathophysiology.
about
Extracellular chaperones modulate the effects of Alzheimer's patient cerebrospinal fluid on Abeta(1-42) toxicity and uptakeGlobal analysis of S-nitrosylation sites in the wild type (APP) transgenic mouse brain-clues for synaptic pathology.Targeting the neurovascular unit for treatment of neurological disorders.Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease.Feasibility study of the BrightBrainer™ integrative cognitive rehabilitation system for elderly with dementia.Association of Serum Manganese Levels with Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-AnalysisStructure of N-terminal sequence Asp-Ala-Glu-Phe-Arg-His-Asp-Ser of Aβ-peptide with phospholipase A2 from venom of Andaman Cobra sub-species Naja naja sagittifera at 2.0 Å resolution.Tacrine, Trolox and Tryptoline as Lead Compounds for the Design and Synthesis of Multi-target Agents for Alzheimer's Disease Therapy.Application of Chitosan, Chitooligosaccharide, and Their Derivatives in the Treatment of Alzheimer's Disease.Beneficial effect of chyawanprash on cognitive function in aged mice.Astrocytic GluN2A and GluN2B Oppose the Synaptotoxic Effects of Amyloid-β1-40 in Hippocampal Cells.The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer's disease in rats.
P2860
Q33838883-45E97FF6-B531-41C0-A7D6-9D6B6C8EC0F4Q34157658-A701AA13-2C51-410D-BAB9-1A0842D5E6D8Q34974827-6BB5C42B-BCA5-4CDD-9569-3BAFFB01B428Q35094556-74EC171F-E087-4B72-B2BE-83397C5584F9Q37089748-5A5C637E-A57B-48A8-8D86-EABF219A8F3AQ37729700-2728D65D-3798-4CE8-AB45-D26B4FB464F0Q38612518-DAA8C9F5-6C03-474B-AE8C-2F07510FAB56Q42289492-866CD0E9-FBB9-42D4-B034-27FCD2A80DC7Q46266855-C0170B44-1369-417E-86FA-9342EDD50A52Q47365737-93B670B5-5B93-4995-899E-6CC83BEC76CCQ48585098-417EF2D6-083B-4734-B3BF-D54657276A7EQ49065735-E735169D-DF47-4117-9096-A056B366D901
P2860
Treatment of Alzheimer's disease: from pharmacology to a better understanding of disease pathophysiology.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Treatment of Alzheimer's disea ...... ng of disease pathophysiology.
@ast
Treatment of Alzheimer's disea ...... ng of disease pathophysiology.
@en
type
label
Treatment of Alzheimer's disea ...... ng of disease pathophysiology.
@ast
Treatment of Alzheimer's disea ...... ng of disease pathophysiology.
@en
prefLabel
Treatment of Alzheimer's disea ...... ng of disease pathophysiology.
@ast
Treatment of Alzheimer's disea ...... ng of disease pathophysiology.
@en
P2093
P1476
Treatment of Alzheimer's disea ...... ng of disease pathophysiology.
@en
P2093
Alessia Lanari
Daniele Tomassoni
Francesco Amenta
Giorgio Silvestrelli
Lucilla Parnetti
P304
P356
10.1016/J.MAD.2005.09.018
P577
2005-11-08T00:00:00Z